| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IL-17 RA | Biotinylated Human IL-17 RA / CD217 Protein, Fc,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug | ||
| IL-17 RA | Cynomolgus IL-17 RA / CD217 Protein, His Tag (MALS verified) | Cynomolgus | HEK293 | ![]() | MALSSDS-PAGE | $315.00 100ug | ||
| IL-17 RA | Human IL-17 RA / CD217 Protein, His Tag | Human | HEK293 | ![]() | SDS-PAGE | $290.00 100ug | ||
| IL-17 RA | Human IL-17 RA / CD217 Protein, Fc Tag (MALS verified) | Human | HEK293 | MALSSDS-PAGE | $295.00 200ug | |||
| IL-17 RA | Mouse IL-17 RA / CD217 Protein, His Tag (MALS verified) | Mouse | HEK293 | ![]() | MALSSDS-PAGE | $315.00 100ug | ||
| IL-17 RA | Rat IL-17 RA / CD217 Protein, Fc Tag (MALS verified) | Rat | HEK293 | ![]() | MALSSDS-PAGE | $315.00 100ug | ||
| IL-17 RA | Avitag ILR-H82E5 | Biotinylated Human IL-17 RA / CD217 Protein, His,Avitag™ | Human | HEK293 | ![]() | SDS-PAGE | $360.00 25ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| XCUR-17 | XCUR-17 | Phase 1 Clinical | Exicure Inc | Psoriasis | Details |
| PN-881 | PN-881 | Phase 1 Clinical | Protagonist Therapeutics Inc | Dermatitis; Psoriasis | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Brodalumab | AMG-827; KHK-4827; IL-17R mAb; MEDI-6365 | Approved | Amgen Inc | Siliq, Lumicef, Kyntheum, 立美芙 | Japan | Psoriasis; Arthritis, Psoriatic | Kyowa Kirin Co Ltd | 2016-07-04 | Arthritis, Psoriatic; Arthritis, Rheumatoid; Asthma; Axial Spondyloarthritis; Brain Neoplasms; Breast Neoplasms; Colonic Neoplasms; Crohn Disease; Esophageal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Hidradenitis Suppurativa; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Mouth Neoplasms; Non-radiographic axial spondyloarthritis; Palmoplantar pustulosis; Pancreatic Neoplasms; Plaque psoriasis; Prostatic Neoplasms; Psoriasis; Pustular psoriasis; Rectal Neoplasms; Scleroderma, Systemic; Skin Neoplasms; Solid tumours; Spondylitis, Ankylosing; Stomach Neoplasms; Testicular Neoplasms; Thyroid Neoplasms | Details |